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Teaching Case Studies: Managing Aberrant Behavior In Patients With Dementia
Objectives
At the end of this case, presentation readers will:
1. Recognize common causes of insomnia in older 
patients with mild cognitive impairment, with 
special emphasis on nocturnal hypoglycemia as 
a cause of sleep maintenance insomnia or middle 
insomnia.
2. Appreciate the nonpharmacological manage-
ment of insomnia.
3. Know potential benefits and drawbacks of sleep 
aids available over-the-counter.
4. Appreciate the usefulness, limitations, and 
adverse effects of commonly used hypnotics.
5. Understand the importance of sleep architecture 
and the main functions of each sleep stage.
Case Presentation
Characters
•• Esther, 72 years old, has mild cognitive impair-
ment, diagnosed about 2 years ago. She also has 
diabetes mellitus, well-controlled by oral hypo-
glycemics. She has been living with her daughter, 
son-in-law, and granddaughter, since her husband 
died about a year ago, because she was unable to 
take care of the large house she lived in. Her 
daughter and son-in-law converted the den into a 
room for her. Esther is physically independent, 
drives her own car and is socially active. Apart 
from the hypoglycemics, she is on no other medi-
cation. Her hearing is impaired; she wears hear-
ing aids.
•• Miranda is Esther’s daughter.
•• Donald is Miranda’s husband.
•• Mary Lee is Miranda and Donald’s 4-year-old 
daughter.
Scenario
It is close to 6:00 p.m. The family is sitting at the dining 
room table. Esther is not hungry and does not eat. 
Miranda asks her if she is going to eat. Esther replies she 
is not really hungry, she’s been sitting all day reading 
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and plans to exercise for at least an hour on the station-
ary bike before going to bed. She explains that she bor-
rowed a 90-min documentary DVD on climate change 
from the library and plans to watch it while exercising. 
Donald asks her if she would like some of the cheese-
cake he bought. Esther again declines, excuses herself 
and goes to exercise on the stationary bicycle.
After exercising for over an hour, Esther returns to 
the front room where Miranda and Donald are watching 
a TV movie. Mary Lee is sleeping in her own room. 
Esther says that she plans to shower and then will head 
straight for bed. She enjoyed her exercise session and 
now feels physically tired but mentally relaxed and 
ready for a good night sleep. “Isn’t it too early for bed?” 
Donald asks. “It’s only about eight in the evening.” 
Esther replies, “No, I’m ready for bed.”
Donald asks, “Aren’t you going to eat anything 
before going to bed? What about the cheesecake I just 
bought?” Esther replies, “No thanks. I’m so tired I’ll fall 
asleep as soon as my head hits the pillow.” Donald per-
sists, “Shall I prepare you a cup of herbal tea or hot 
chocolate or how about some cookies?” Esther replies, 
“No thanks. I’ll just shower and then go to straight to 
bed.” Almost in unison Miranda and Donald say, “OK, 
have a good night’s sleep.”
Miranda is somewhat concerned: “Do you think she 
is depressed? She hardly touched her food and had noth-
ing to eat since we had that cup of tea when you came 
back from work.” Donald is not concerned. He only 
hopes she has a good night’s sleep because he has a very 
heavy day at work the following day and plans to leave 
home at about 5:00 a.m. He says,
My main concern is that we have a repeat of last week 
when she woke up at about 2:00 a.m., could not fall asleep 
and tried to prepare breakfast. In the process she made so 
much noise that she even woke up the neighbors.
On the way to their bedroom they notice that lights are 
out in Esther’s room. “Keep your fingers crossed.” 
Donald murmurs in Miranda’s ear as they head toward 
their bedroom.
It is about 2:00 a.m. Everybody is sound asleep 
except for Esther. She’s been awake for about 30 min. 
She goes to the bathroom again, then returns to bed. She 
cannot sleep. She tosses and turns and is wide-awake. 
She tries to read but gives up. She looks for her hearing 
aids but drops them on the floor and cannot reach them 
because they rolled under her bed. She switches on the 
TV but cannot hear so she increases the volume so high 
that it wakes up Miranda and Donald. Very quickly, an 
altercation develops between Miranda and Donald. 
Tempers flare. Now Mary Lee is awake and crying. 
Donald states that the time has come for Esther to be 
placed in a nursing home or assisted living facility 
because he needs a full night sleep: “This cannot con-
tinue! Your mother is jeopardizing my career and 
destroying our marriage.”
Case Analysis
Turning Points/Triggers That Lead to This 
Aberrant Behavior Include
No food/drink for a few hours before going to bed. Esther 
did not have dinner and it is questionable how much she 
ate earlier that day. Therefore, by 2:00 a.m. her blood 
glucose levels would have been sufficiently low to stim-
ulate the sympathetic nervous system and release of cat-
echolamines (adrenaline and noradrenaline) which 
would then wake her up and induce anxiety and irritabil-
ity (Borbely, Mattmann, Loepfe, Strauch, & Lehmann, 
1985). The catecholamine surge also may induce car-
diac arrhythmias, which may reduce the stroke volume, 
cardiac output, and subsequently cerebral blood flow 
and perfusion thus worsening the patient’s cognitive 
deficit. Nocturnal hypoglycemia is likely to occur in 
Assisted Living Facilities and nursing homes when the 
last substantial meal of the day can be served as early as 
5:00 p.m. Even though snacks are usually available later 
in the evening and night, residents may not eat them, 
because they often do not feel hungry or have difficul-
ties reaching the dining area.
Esther also has diabetes mellitus and is on oral hypo-
glycemics. As such, she is much more likely to develop 
bouts of hypoglycemia. The impact of hypoglycemia is 
significant in terms of sleep quality and next-day func-
tion (Brod, Wolden, Christensen, & Bushnell, 2013; 
Evans et al., 2013; Harris et al., 2014), even among the 
younger population with diabetes mellitus (Brod, 
Christensen, & Bushnell, 2012; Fulcher et al., 2014; 
Iscoe & Riddell, 2011; Jennum et al., 2015; Khunti et al., 
2016; Klimontov & Myakina, 2017; Munshi et al., 2011; 
Porcellati, Lin, Lucidi, Bolli, & Fanelli, 2017; Speight 
et al., 2016; Yang, Kim, Baek, Kim, & Park, 2016).
Could it have been avoided? Esther should have been 
encouraged to eat dinner regardless of whether she was 
feeling hungry. This would have ensured that her plasma 
glucose level does not drop to the extent of stimulating 
the sympathetic nervous system. Similarly, after exercis-
ing, she should have had a healthy snack: for example, 
a glass of milk, chocolate, or hot herbal tea with honey 
and a few cookies. This would provide the patient with 
enough glucose and complex carbohydrates to prevent 
the plasma glucose level from dropping during the night.
Sugary drinks contain sucrose which breaks down 
into glucose, but their effect on plasma glucose levels is 
short-lived. The effect of complex carbohydrates on the 
blood glucose level is much longer lasting because they 
first have to be digested and then absorbed through the 
intestines. Hence, a good combination is a hot sugary 
drink and complex carbohydrate, such as a couple of 
cookies or a slice of whole grain bread. The sugary 
drinks will have an almost immediate effect on plasma 
glucose level that may last a few hours, especially if 
consumed hot as this may enhance absorption through 
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the gastro-intestinal tract. Ice cream is another option. 
Efforts therefore should have been made to emphasize 
that in Esther’s case the purpose of eating is to ensure a 
good night’s sleep and should be taken “for medicinal 
purposes” regardless of whether or not Esther feels 
hungry.
Hypoglycemia could be confirmed by assaying the 
blood glucose level. The very early nocturnal awaken-
ing and ensuing episode could have easily been avoided 
had Esther eaten or had a hot sugary drink with a few 
cookies or some of the cheesecake her son-in-law bought 
earlier that day. As a similar episode happened earlier 
that week, it should not have been too difficult to con-
vince Esther of the need to eat and drink before going to 
bed. It also would have been very useful to measure her 
blood glucose level and share the results with her physi-
cian to ensure she is getting the right medication, in the 
right dose for her diabetes. Patients treated for diabetes 
are more likely to develop hypoglycemia.
Physical exertion and showering before going to bed. During 
physical exertion, the liver and muscles break down their 
glycogen stores to produce glucose which is needed to 
meet the energy needs of the exercising muscles. When 
exercise stops, the liver and muscles extract glucose from 
the blood stream to replenish their glycogen stores (Oda 
& Shirakawa, 2014). This may occur over a period of a 
few hours and may lead to hypoglycemia.
Strenuous exercise increases body temperature which 
also may interrupt sleep. Esther exercised for over an 
hour and then proceeded to shower before going to bed. 
Depending upon the temperature of the water and dura-
tion of the shower her body temperature could have been 
kept elevated. Having Esther exercise earlier in the day 
may also increase her appetite and desire to eat dinner.
Could it have been avoided? This episode could have 
been avoided had Esther exercised and showered earlier 
in the day.
Esther sleeps in a windowless room: A converted den. There 
are no windows in Esther’s room, as such, she is not get-
ting any visual cues about the time of the day or night to 
adjust her circadian rhythm. When she wakes up, she 
has no idea what time it is and whether or not she should 
stay in bed and be quiet while her daughter, son-in-law 
and granddaughter are still sleepy.
Could it have been avoided? A large well-lit, visible 
wall clock or the time projected on the wall immediately 
across her bed would have reminded Esther of the time 
of the day, would have helped her readjust her circadian 
rhythm, and would have encouraged her either to stay 
in bed or to be quiet so as not to wake up the rest of the 
household.
Esther dropped her hearing aids and could not retrieve 
them. This prevented Esther from hearing the TV and as 
a result she had to increase the volume to such an extent 
that it woke up the rest of the household.
Could it have been avoided? Given that hearing is such 
an important element of communication with other people 
and that hearing aids are so important to a person sharing 
accommodation with others, they should be easily accessi-
ble, even in the dark, especially if the person lives in a win-
dowless room, as is the case with Esther. Hearing aids or 
headphones should be kept in an illuminated easily acces-
sible container or tray. Similarly, sound from the TV could 
be channeled straight to the patient’s ears through earplugs 
or headphones. These are easier to use than hearing aids 
which need to be inserted through the external auditory 
meatus: a particularly difficult task in a person who has just 
woken up and may have apraxia as part of the underlying 
neurocognitive disorder. A small night light bulb with red 
wavelengths could be utilized for visibility without hinder-
ing sleep (Brainard et al., 2015; Schmerler, 2015).
Esther turned on the TV. As Esther did not have her hear-
ing aids, she was unable to hear the TV without increas-
ing the volume to such an extent that it woke up Miranda 
and Donald then subsequently Mary Lee.
Could it have been avoided? The TV could have been 
connected electronically to her hearing aids or head-
phones. This would have allowed her to increase the 
volume as high as needed without anyone else being 
even aware that the TV is switched on.
If possible, it may have been better to have Esther’s 
room in a more remote part of the house where any noise 
generated by Esther would not be easily transmitted to 
the other bedrooms. Sound proofing would be another 
option, albeit an expensive one.
Still another option would have been not to have a 
TV in Esther’s bedroom, especially as the light rays 
emitted from the TV may interfere with the release of 
melatonin from the pineal body in the brain and this per 
se, may interfere with the circadian rhythm.
Stress, depression, and insomnia. Stress and Depression 
oftentimes follows the death of a loved one and major 
life changes. Given that within the past year, Esther not 
only lost her husband but also moved out of her home 
into her daughter’s home, Esther could have been expe-
riencing undiagnosed stress and/or depression. Depres-
sion interferes with sleep: patients tend to wake up early 
in the morning and have a difficult time falling back to 
sleep. Early morning awakening is indeed one of the 
common manifestations of depression. The stress of 
these major life changes could have increased Esther’s 
cortisol level, which also contributes to insomnia (Botts, 
2010; Dumbell, Matveeva, & Oster, 2016; Spencer, 
Chun, Hartsock, & Woodruff, 2017).
Could it have been avoided? It is important to ascertain 
whether Esther is depressed. Screening for depression is 
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recommended in all older patients, especially those with 
mild cognitive impairment. The successful management 
of depression is often associated with an improvement 
of cognitive functions. A number of screening question-
naires are available.
It is also important to detect suicidal ideation, as the 
potential for suicide is high in older people, especially 
men, particularly those who live on their own. In Esther’s 
case, it is therefore relevant to evaluate her for depres-
sion and suicidal ideation. Depression and suicidal ide-
ation in patients with impaired cognitive functions are 
discussed in subsequent case studies.
Case Discussion: Scope of the 
Problem
Chronic insomnia is defined as difficulties falling asleep 
or remaining asleep occurring 3 or more times a week 
for 1 or more month (Winkleman, 2015; Diagnostic and 
Statistical Manual of Mental Disorders [5th ed.; DSM-
5]; American Psychiatric Association, 2013). It affects 
about one third of the adult population (Winkleman, 
2015). About 50% of patients with chronic insomnia 
have underlying psychiatric diseases including depres-
sion, suicidal ideation, anxiety, impaired cognitive func-
tions, and dementia (Winkleman, 2015). Sleep 
complaints are associated with an increased mortality of 
common diseases such as ischemic heart diseases, cere-
bro-vascular accidents and neoplastic lesions 
(Gooneratne et al., 2006). Not diagnosing or misdiag-
nosing the cause of insomnia may have serious nefari-
ous outcomes such as when sleep apnea is missed and 
the patient prescribed a hypnotic or a sedative 
(Trevorrow, 2010). The incidence of insomnia is higher 
in older than younger adults and is associated with poor 
health and cognitive impairment (Ancoli-Israel, 2009; 
Arbus & Cochen, 2010).
Diagnostic Criteria of Insomnia (DSM-5)
Insomnia is defined as a dissatisfaction with the quantity 
or quality of sleep due to difficulties initiating sleep 
(sleep-onset or initial insomnia), maintaining sleep 
(sleep maintenance or middle insomnia), or early morn-
ing awakening with inability to return to sleep (late 
insomnia), occurring at least 3 times a week for at least 
1 month, despite adequate opportunities to sleep and 
provided it is not due to another medical or mental dis-
ease, the effects of medication or substance abuse, 
including alcohol and is not due to another sleep-wake 
disorder (DSM-5). Patients with nonrestorative sleep 
complain of a poor sleep quality and of not feeling rested 
or refreshed on waking up: They still feel tired.
Apart from nighttime sleep difficulties, insomnia is 
often associated with worsening cognitive impairment, 
especially difficulties with attention, concentration, 
memory, and performance of simple daily tasks. Patients 
are also often irritable, anxious, depressed, and may 
exhibit mood lability.
Causes of Insomnia
The causes of insomnia can be classified into three 
groups: extrinsic causes, intrinsic causes, and those 
related to the individual’s lifestyle.
Extrinsic causes of insomnia include change of bed/
bedroom, uncomfortable bed, noise, excessive lighting, 
too low or too high an environmental temperature, and 
excessive humidity or dryness. A number of medications 
also may induce insomnia including selective serotonin 
reuptake inhibitors, theophylline, thyroid hormone, 
diuretics, beta-blockers, antiarrhythmics, clonidine, 
sympathomimetic stimulants, corticosteroids, and medi-
cations containing caffeine. Over-the-counter medica-
tions also may predispose to insomnia including nicotine 
replacement, energy boosters, and other preparations 
containing alcohol or caffeine.
Intrinsic causes include a number of diseases which 
may interfere with the quantity and quality of sleep 
including restless leg syndrome, sleep apnea, gastro-
esophageal reflux disorders (giving rise to heartburn), 
chronic obstructive airways disease (dyspnea), noctur-
nal asthma (dyspnea), congestive heart failure (dyspnea, 
orthopnea, paroxysmal nocturnal dyspnea, nocturnal 
polyuria), coronary artery disease (chest pain), arrhyth-
mias (palpitations), diabetes mellitus (polyuria, periph-
eral neuropathies, peripheral vascular disease), 
inflammatory conditions (pain), arthropathies (pain), 
respiratory tract infections (cough, dyspnea), urinary 
tract infections (dysuria and frequency), any infection 
(pain), renal calculi (pain), and neoplasia (pain). Obesity 
also predisposes to insomnia. A number of psychiatric 
disorders also may induce insomnia.
Several lifestyle habits also may induce insomnia 
including having naps throughout the day, consuming 
heavy meals or undertaking strenuous physical exer-
cises shortly before going to bed, excessive alcohol or 
caffeine intake before going to bed and mental stress. 
Other habits that may detrimentally affect the quantity/
quality of sleep include watching TV, using a laptop 
computer, or other electronic devices shortly before 
going to bed, or while in bed. These may interfere with 
melatonin production and the circadian rhythm. If it is 
necessary to use these technologies before bedtime, it is 
recommended to use the night shift capabilities which 
will diminish the blue light and display the more yel-
low–orange end of the spectrum (Gronli et al., 2016).
In many instances it is not one factor, but rather a 
combination of factors that lead to insomnia: Each fac-
tor on its own may not be sufficient to induce insomnia, 
but the combination of factors leads to insomnia. It is 
therefore important to identify these factors and address 
them while managing insomnia. As much as possible 
hypnotics should be prescribed only after identifying 
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and addressing the cause(s) of the insomnia (Arbus & 
Cochen, 2010).
Assessing the Severity and Impact of 
Insomnia
Given that assessment of sleep quality and quantity is 
such a subjective individual issue, a number of question-
naires are available to objectively assess sleep quality and 
quantity (Trevorrow, 2010). A good sleep history from the 
patient and bedroom partner, if available, is the first step 
in assessing the type and severity of the insomnia taking 
into account the various extrinsic factors that may lead to 
insomnia. Enquiries should also be made about the 
patient’s lifestyle habits that may affect sleep. A thorough 
clinical examination is then recommended to identify the 
cause(s) of the insomnia. Depending on the findings, a 
few laboratory tests and imaging studies may be required.
A number of procedures can be used to assess sleep 
quality and quantity including electroencephalograms 
(EEGs), polysomnography, audio and video recordings, 
measurement of various physiological parameters such 
as pulse rate, respiratory rate, eye movement, arousal 
thresholds, and a number of other parameters. Sleep 
laboratories are also widely available, although it should 
be pointed out that only a small number of patients will 
require such studies.
A number of smartphone apps, devices, and gadgets 
are becoming available to track sleep pattern and offer 
targeted advice that may help achieve a better sleep pat-
tern. Some of these devices also provide cranial stimula-
tion. Unfortunately, the background research on most of 
these is limited and their long-term efficacy and safety 
are not known.
Management of Insomnia
Although managing insomnia, all three groups of factors 
(extrinsic, intrinsic, and lifestyle habits) need to be 
addressed to tailor the management strategy to the indi-
vidual circumstances of the particular patient and maxi-
mize the impact of the management strategy. Although 
managing insomnia nonpharmacological means should 
be tried before prescribing hypnotics. Regardless of the 
cause(s) of insomnia, good sleep hygiene promotes 
restorative, good quality, and good quantity sleep.
A number of nonpharmacologic measures are avail-
able to manage insomnia. Their success largely depends 
on the cooperation of the patient, her motivation and 
willingness to pursue these lines of management. Sleep 
specialists trained in behavioral medicine may be able to 
help patients with insomnia replace lifestyle habits 
responsible for their insomnia with good habits that 
enhance the quality and quantity of sleep and its restor-
ative functions. The goal of relaxation techniques is to 
train the patient to relax and free herself of mental 
impediments to sleep.
The main goal of sleep restriction to manage insom-
nia is to increase the patient’s sleep drive by reducing 
the time in bed (but no less than 5 hr per 24 hr) and 
inducing a sleep debt. The patient is expected to respond 
by sleeping better during the hours she is allowed to 
sleep, thus normalizing her circadian rhythm (Phillips, 
Klerman, & Butler, 2017). Once the patient responds 
favorably, the amount of time spent in bed is gradually 
increased.
The main goal of cognitive behavioral therapy (CBT) 
is to restructure the patient’s dysfunctional behaviors 
and/or beliefs that perpetuate insomnia. As a result, 
sleep latency is shortened, frequency and duration of 
nocturnal awakenings are reduced and total sleep time is 
lengthened (Cervena et al., 2004). The main limitations 
of CBT include the number of sessions required to 
achieve good results, the relatively small number of 
therapists available and the low patient adherence. Web-
based CBT is available and may be helpful.
Sleep Hygiene: Measures to Improve Quality 
and Quantity of Sleep
Sleep quality and quantity may be improved by going to 
bed at about the same time every day, including week-
ends. If the individual cannot sleep within 20 to 30 min, 
she should not stay in bed. She should get out of bed, get 
engaged in some relaxing activity and then return to bed 
when she feels tired. Watching TV may be counterpro-
ductive, especially if watched in bed and if the program 
watched is violent, scary, or needs the individual to con-
centrate on the show such as watching mystery movies. 
Ideally, the material watched should be light-hearted 
and relaxing.
Physical exercise is recommended, but not within 2 
hr of bedtime. Vigorous physical exercise is associated 
with an increased production of catecholamines and 
stimulation of the sympathetic nervous system which 
interfere with sleep. A hot sweet drink, preferably with 
honey and accompanied by one or two cookies, about 30 
min before going to bed will ensure the blood glucose 
levels do not drop while the patient is asleep. A warm 
bath before going to bed will help relax the patient.
The bedroom should be dark or dimly lit, not noisy 
and be at a comfortable temperature and degree of 
humidity. The mattress should be firm, the bedsheets 
clean with no wrinkles and no foreign bodies such as 
breadcrumbs, food particles, or other material. Pillows 
should be comfortable.
Sleep Hygiene: Measures to Avoid to Improve 
Quality and Quantity of Sleep
Mentally demanding, irritating activities should be avoided 
for at least an hour before going to bed. The following 
should be avoided within 2 hr of going to bed: naps, 
vigorous physical exercise, tobacco use, heavy meals 
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especially spicy food which may induce heartburn, alco-
holic drinks, high fluid intake (the induced polyuria may 
interfere with sleep quality and quantity), and caffeine 
containing drinks and food, such as dark chocolate.
Nonprescription, Over-the-Counter, 
Pharmacologic Management of Insomnia
The primary active ingredient of most nonprescription 
sleeping tablets is an antihistamine compound such as 
diphenhydramine or doxylamine. Antihistaminics are 
also acetylcholine antagonists. Per se they are not 
hypnotics, but, given their sedating effect, they induce 
drowsiness and thus help the person initiate and 
maintain sleep. Short-term adverse effects include diz-
ziness, impaired coordination, nausea, headaches, 
constipation, dysuria, urinary retention, palpitations, 
tachycardia, thickened bronchial secretions, diaphore-
sis, and blurred vision. Their administration also may 
induce cognitive impairment and toxic psychosis, 
especially in older people. They also may induce 
unsteadiness and increase the risk of falls. This can be 
quite problematic in older patients with dementia espe-
cially as the half-life of these medications tends to be 
prolonged in older people. Alcohol intake also potenti-
ates their effect. Although these medications have been 
available for a very long time, their long-term safety is 
not known.
Dietary Supplements
Dietary supplements do not come under the regulation 
of the Food and Drug Administration (FDA). As such, 
therefore, they are rigorously tested for neither safety 
nor effectiveness. Similarly, their quality and label accu-
racy are not verified by the FDA. Furthermore, although 
touted as “natural” some may contain other active bio-
logic ingredients that may not be mentioned on the 
package or label, but nevertheless may interact with 
other medications. It is therefore relevant to enquire 
about any “dietary supplement” the patient may be tak-
ing on a regular basis and identify any possible interac-
tion with the patient’s other medications.
Valerian and chamomile are readily available and 
often touted as sleeping aids. Valerian root extract, how-
ever, contains more than 100 specifically identified sub-
stances (Harvard Medical School Special Health Report, 
2013). Our understanding of the mode of action of these 
compounds is still limited.
Melatonin
Melatonin facilitates sleep initiation and improves sleep 
quality without altering sleep architecture (Zhdanova, 
2005). The effects of melatonin are mediated through 
specific melatonin receptors. The response to melatonin 
in older people, however, is often reduced because of the 
often age-related reduced functional potency of melato-
nin receptors (Zhdanova, 2005).
Melatonin is available over the counter and often 
used to induce sleep. A review of the available literature 
by the Agency for Health care Research and Quality 
concluded that melatonin reduced sleep latency to a 
greater extent in people with delayed sleep phase syn-
drome, suggesting that it exerts its effects by resetting 
the circadian rhythm rather than acting as a hypnotic 
(Buscemi et al., 2004). Melatonin also may be effective 
at alleviating the effect of symptoms of jet lag (Vosko, 
Coldwell, & Avidan, 2010). The administration of exog-
enous melatonin is safe in the short term (Buscemi et al., 
2004).
Melatonin is synthesized from tryptophan in the 
pineal body, located behind the third ventricle in the 
brain. Approximately 90% of melatonin is cleared in a 
single passage through the liver. A small proportion is 
excreted unchanged in the urine. Long-term effects and 
safety of melatonin are not known.
Hypnotics
A number of hypnotics are available to induce sleep. 
Although they should be used in the lowest dose and for 
the shortest period, to maintain their efficacy and limit 
the adverse effects, many patients are on hypnotics for 
long periods of time. Four main classes of hypnotics are 
available: benzodiazepines, nonbenzodiazepines, anti-
depressants and melatonin receptor agonist.
Benzodiazepines act by enhancing the activity of the 
neurotransmitter Gamma Aminobutyric Acid (GABA). 
The profile of various benzodiazepines is dependent on 
their half-lives and how quickly and for how long their 
action lasts. Their main drawback is that they alter sleep 
architecture (Borbely et al., 1985; Wagner & Wagner, 
2000). The sleep they induce is therefore not as restor-
ative as natural sleep. Their main adverse effects include 
psychomotor and memory impairment, next-day 
impaired mental alertness, sedation, drowsiness, and 
unsteadiness that may increase the risk of falls. Other 
side effects include exacerbation of depression and sui-
cidal ideation, aggressive behavior, amnesia, and halluci-
nations. Many patients develop tolerance and need higher 
doses. Abruptly stopping their administration often leads 
to rebound insomnia with an increased risk of restless-
ness, irritability, and rarely convulsions. Benzodiazepines 
are best suited for the short-term treatment of insomnia. 
Available benzodiazepines have a wide range of half-
lives: triazolam (1.5 to 5.5 hr), temazepam (8.8 hr), 
alprazolam (12 to 16 hr), lorazepam (14 hr), estazolam 
(10 to 24 hr), clonazepam (20 to 50 hr), diazepam (30 to 
50 hr), and flurazepam (40 to 100 hr).
Nonbenzodiazepines are at least as effective as ben-
zodiazepines at inducing sleep and improving subjective 
sleep quality (Uchimura et al., 2006). Their main advan-
tages include their relatively short half-life and that they 
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induce less psychomotor and memory impairment than 
benzodiazepines and antidepressants (Schneider, 2002). 
They, nevertheless alter the sleep architecture, espe-
cially in older patients, albeit to a lesser extent than ben-
zodiazepines (Chinoy, Frey, Kaslovsky, Meyer, & 
Wright, 2014). Their main adverse effects include nau-
sea, headaches, drowsiness, dizziness, repeated falls, 
nightmares, disorientation, agitation, and somnambu-
lism, including nocturnal eating, walking, and even 
driving. Dependence, rebound insomnia and withdrawal 
symptoms occur less frequently than with benzodiaze-
pines (Wagner & Wagner, 2000). Available nonbenzodi-
azepines used for insomnia have shorter half-life: 
Zaleplon (1 hr), zolpidem (2.5 to 3.1 hr), and eszopi-
clone (6 hr). Extended release preparations are available 
but are associated with changes in sleep architecture and 
impaired physical performance during nighttime awak-
ening and the following day and therefore may impact 
nefariously on the patient’s safety (Kleykamp, Griffiths, 
McCann, Smith, & Mintzer, 2012).
A number of antidepressants are also used for the 
management of patients with insomnia, including the 
following: Selective Serotonin Reuptake Inhibitors 
(citalopram, fluoxetine, fluvoxamine, paroxetine, and 
sertraline), Serotonin and Norepinephrine Reuptake 
Inhibitor (venlafaxine), Serotonin modulator (trazo-
done), tetracyclic (mirtazapine), and tricyclics (amitryp-
tiline, doxepin, nortryptiline, and trimipramine). Main 
adverse effects include dry mouth, dizziness, daytime, 
and drowsiness. Ramelton is a melatonin receptor ago-
nist. Its main adverse effect is that it may exacerbate 
depression.
Sleep Structure/Architecture and Cycles
Nocturnal sleep occurs in cycles. It has two distinct 
components: Quiet sleep and Rapid Eye Movement 
(REM) sleep. Dreams occur during the latter compo-
nent. Quiet sleep is also known as non-REM sleep and 
has three stages.
The first stage: “Quiet or non-REM sleep” represents 
the transition between wakefulness to light sleep. During 
this stage, the eyes close and the brain, deprived of 
visual input, slows down. At the beginning of this stage, 
brain waves on the EEG are in the “alpha-wave pattern,” 
a rhythmic pattern of about 10 cycles per second. As 
Stage 1 progresses brain waves on the EEG slow down 
to 4 to 7 per second: “theta wave pattern.” Thinking 
slows down as well as the heart rate, breathing rate, and 
most physiological activities. Body temperature starts to 
fall. Muscles relax but movement may still occur and the 
person may change positions looking for a most com-
fortable position. Eyes move slowly. The person gradu-
ally loses spatial orientation, but is easily jarred awake. 
Stage 1 of non-REM sleep is often referred to as “an 
idling brain in a movable body” and usually lasts about 
5 min.
During the second stage of non-REM sleep the eyes 
are closed, not moving, the heart rate and respiratory 
rate slow down further, EEG exhibits large slow waves 
intermingling with bursts of activity known as sleep 
spindles. Body temperature decreases. The brain discon-
nects itself from outside sensory input and begins the 
process of memory consolidation. On the EEG 
K-complexes are evident: They represent a sort of vigi-
lance system that, if necessary, allows the person to 
wake up. Stage 2 lasts 10 to 25 min. If the person is not 
woken up, she proceeds to Stage 3.
During the third stage, also known as deep sleep, 
large slow waves: “delta waves” become prominent on 
the EEG. This stage is also sometimes referred to as the 
“Slow Wave Sleep.” The blood pressure drops, breath-
ing and heart rates slow down further to about one third 
below the level during wakefulness. The brain is less 
responsive to external stimuli and it is difficult to wake 
up the person sleeping in this stage. During this stage, 
the pituitary gland releases growth hormone which stim-
ulates tissue growth and allows the body to renew and 
repair itself. The immune system is also stimulated. This 
stage lasts about 30 min in young adults, but gets pro-
gressively shorter as individuals age. When subjects are 
deprived of this stage, they wake up feeling less 
refreshed and when offered the opportunity of sleeping 
again, tend to rapidly descend to the third stage, thus 
spending more time in this stage and less time in Stages 
1 and 2.
REM sleep is characterized by dreaming and has 
been described as an “active brain in a paralyzed body”: 
the eyes, while closed, move rapidly, body temperature 
rises, blood pressure increases, heart, and breathing 
rates increase. The sympathetic nervous system is acti-
vated and launches the fight-or-flight response, but the 
body is essentially paralyzed except for occasional 
twitches and the REMs. During this stage, the brain pro-
cesses information received during the day. REM-sleep 
facilitates learning and enhances memory. The initial 
REM-sleep stage lasts only a few minutes, but as the 
night progresses this stage tends to become longer. In a 
way, the body having physically repaired and renewed 
itself during the third stage, now addresses the person’s 
mental and cognitive functions. When persons who have 
been deprived of REM sleep are allowed to sleep unin-
terrupted, they rapidly go to the REM-sleep stage. This 
is referred to as “REM rebound.”
Non-REM sleep alternates with REM sleep, each 
cycle lasts 60 to 90 min. On average people go through 
three to five cycles a night. As the night progresses, the 
time spent in REM and Stage 1 sleep gets longer, while 
Stage 3 gets shorter and may be altogether absent.
As individuals grow older, sleep latency, which is the 
time needed to transition from wakefulness to Stage 1 
non-REM sleep tends to be prolonged, while the total 
duration of nocturnal sleep tends to decreases. Similarly, 
time spent in Stage 2 increases while the time spent in 
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Stage 3 and REM-sleep decreases. Sleep is also more 
fragmented and daytime naps are more frequent than in 
younger adults (Arbus & Cochen, 2010).
Summary/Teaching Points
•• Nocturnal hypoglycemia is a cause of sleep dis-
turbances: middle or late insomnia and is often 
precipitated by lack of food or physical exertion 
before going to bed.
•• Causes of insomnia can be classified into three 
groups due to extrinsic factors, intrinsic factors, 
and lifestyle habits. All three groups should be 
addressed as often the etiology of insomnia, espe-
cially in older patients with dementia is 
multifactorial.
•• Sleep hygiene plays an important role in maxi-
mizing the quality and quantity of sleep. Patients 
and caregivers should be made aware of the vari-
ous measures to undertake and those that need to 
be avoided. Sleep hygiene should be prescribed 
to patients with insomnia, in conjunctions with 
other measures taken.
•• A number of dietary supplements and sleep aids 
are available. They are not regulated by the FDA. 
There is a paucity of good research on their use to 
facilitate and maintain sleep.
•• A number of nonprescription medications are 
available. The active ingredient in most is an 
antihistamine compound such as diphenhydr-
amine. They are not hypnotics, but induce 
drowsiness which may lead to unsteadiness and 
falls. They tend to have long half-lives and 
therefore physical and mental performance the 
following day(s) may be impaired, particularly 
in older patients.
•• Melatonin is available over-the-counter in the 
United States. It is secreted by the pineal body 
and helps maintain the circadian rhythm. It facili-
tates sleep initiation and improves sleep quality 
without altering sleep architecture.
•• Prescription hypnotics include benzodiazepines, 
nonbenzodiazepine, antidepressants and a mela-
tonin receptor agonist. The former three alter 
sleep architecture to various degrees and there-
fore may interfere with the quality of the sleep 
they induce.
•• Strategies to reduce the impact of watching TV 
on other cohabitants include using a headset con-
nected directly or electronically to the TV, using a 
room as far away as possible from other bed-
rooms and sound proofing the TV room.
•• Circadian rhythm disorders can be helped by a 
large wall clock visible from a distance, a 24-hr 
clock, exposure to bright lights early afternoon to 
reset the melatonin diurnal rhythm and adminis-
tration of melatonin in late evening.
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